Botanix Pharmaceuticals Limited

ASX:BOT Rapporto sulle azioni

Cap. di mercato: AU$645.2m

Botanix Pharmaceuticals Gestione

Gestione criteri di controllo 1/4

Botanix Pharmaceuticals Il CEO è Howie McKibbon, nominato in Aug2023, e ha un mandato di 1.25 anni. la retribuzione annua totale è A$ 3.92M, composta da 15.3% di stipendio e 84.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.22% delle azioni della società, per un valore di A$ 1.42M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1 anni e 5.3 anni.

Informazioni chiave

Howie McKibbon

Amministratore delegato

AU$3.9m

Compenso totale

Percentuale dello stipendio del CEO15.3%
Mandato del CEO1.3yrs
Proprietà del CEO0.2%
Durata media del managementless than a year
Durata media del Consiglio di amministrazione5.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Will Botanix Pharmaceuticals (ASX:BOT) Spend Its Cash Wisely?

Mar 21
Will Botanix Pharmaceuticals (ASX:BOT) Spend Its Cash Wisely?

Here's Why We're Watching Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

Sep 06
Here's Why We're Watching Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

Botanix Pharmaceuticals (ASX:BOT) Will Have To Spend Its Cash Wisely

Jan 03
Botanix Pharmaceuticals (ASX:BOT) Will Have To Spend Its Cash Wisely

Can Botanix Pharmaceuticals (ASX:BOT) Afford To Invest In Growth?

Sep 05
Can Botanix Pharmaceuticals (ASX:BOT) Afford To Invest In Growth?

Here's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

May 10
Here's Why We're Not At All Concerned With Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Situation

We're Not Very Worried About Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate

Jan 12
We're Not Very Worried About Botanix Pharmaceuticals' (ASX:BOT) Cash Burn Rate

We Think Botanix Pharmaceuticals (ASX:BOT) Can Afford To Drive Business Growth

Jul 01
We Think Botanix Pharmaceuticals (ASX:BOT) Can Afford To Drive Business Growth

We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

Mar 18
We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

The Botanix Pharmaceuticals (ASX:BOT) Share Price Has Gained 81% And Shareholders Are Hoping For More

Jan 24
The Botanix Pharmaceuticals (ASX:BOT) Share Price Has Gained 81% And Shareholders Are Hoping For More

We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

Nov 30
We're Hopeful That Botanix Pharmaceuticals (ASX:BOT) Will Use Its Cash Wisely

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Howie McKibbon rispetto agli utili di Botanix Pharmaceuticals?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024AU$4mAU$602k

-AU$14m

Mar 31 2024n/an/a

-AU$12m

Dec 31 2023n/an/a

-AU$10m

Sep 30 2023n/an/a

-AU$10m

Jun 30 2023AU$1mAU$542k

-AU$9m

Mar 31 2023n/an/a

-AU$10m

Dec 31 2022n/an/a

-AU$11m

Sep 30 2022n/an/a

-AU$12m

Jun 30 2022AU$585kAU$126k

-AU$13m

Compensazione vs Mercato: La retribuzione totale di Howie ($USD 2.54M ) è superiore alla media delle aziende di dimensioni simili nel mercato Australian ($USD 927.07K ).

Compensazione vs guadagni: La retribuzione di Howie è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Howie McKibbon

1.3yrs

Mandato

AU$3,923,813

Compensazione

Dr. Howie McKibbon serves as Chief Executive Officer since August 24, 2023 and was its Chief Operating Officer since October 2022 until August 24, 2023. He served as Chief Commercial Officer at Botanix Pha...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Vincent Ippolito
MD & Executive Chairman5.3yrsAU$612.70k0.59%
A$ 3.8m
Howie McKibbon
Chief Executive Officer1.3yrsAU$3.92m0.22%
A$ 1.4m
Graeme Morissey
Chief Financial Officerless than a yearAU$186.22kNessun dato
Matthew Callahan
Executive Director4.8yrsAU$357.12k4.1%
A$ 26.5m
Jack Hoblitzell
Senior Vice President of Pharmaceutical Development3.8yrsNessun datoNessun dato
Patricia Walker
Chief Medical Adviser2.8yrsNessun datoNessun dato
Boris Meyerson
Chief Business Officerless than a yearNessun datoNessun dato
David Morgan
Head of Corporate Affairsless than a yearNessun datoNessun dato
Kevin Wojciechowski
Head of HCP Marketing & Sales Trainingless than a yearNessun datoNessun dato
Susan Park
Company Secretary1.6yrsNessun datoNessun dato
Darin Van Arsdale
Director of Sales Operationsless than a yearNessun datoNessun dato

1.0yrs

Durata media

58yo

Età media

Gestione esperta: Il team dirigenziale di BOT non è considerato esperto (durata media 1 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Vincent Ippolito
MD & Executive Chairman5.3yrsAU$612.70k0.59%
A$ 3.8m
Matthew Callahan
Executive Director4.8yrsAU$357.12k4.1%
A$ 26.5m
Stewart Washer
Independent Non-Executive Director5.8yrsAU$61.57k0.12%
A$ 770.4k
Henry Bosch
Non Executive Director8.3yrsAU$227.16k1.04%
A$ 6.7m
Daniel Sharp
Non-Executive Director2.7yrsAU$88.49k0.12%
A$ 756.6k

5.3yrs

Durata media

54yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di BOT sono considerati esperti (durata media dell'incarico 5.3 anni).